Keybank National Association Novo Cure LTD Transaction History

Keybank National Association

  • $25.5 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021
SELL
$130.4 - $225.58 $257,800 - $445,971
-1,977 Closed
0 $0
Q1 2021

May 07, 2021
SELL
$124.11 - $190.17 $113,808 - $174,385
-917 Reduced 31.69%
1,977 $261,000
Q3 2020

Oct 29, 2020
BUY
$58.05 - $111.31 $167,996 - $322,131
2,894 New
2,894 $322,000

Others Institutions Holding NVCR

# of Institutions
262
Shares Held
77M
Call Options Held
1.17M
Put Options Held
318K
View Full List

About NovoCure Ltd

NVCR Quotes by TradingView
  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $3.04B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Keybank National Association Portfolio

Follow Keybank National Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Keybank National Association with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email